Amy DiRico

Amy DiRico has over 17 years of experience in the pharmaceutical industry. Amy began their career in 2003 as the Director of Clinical Study and Data Management at Pfizer. In 2007, they took on the role of Project Manager at BLC Consulting. In 2010, they became the Clinical Project Manager at CE3 Inc. In 2017, they joined Quartet Medicine as the Director of Clinical Operations and Rodin Therapeutics as the Senior Director of Clinical Operations. In 2020, they became the Senior Director of Development Operations at Third Harmonic Bio. Amy is currently the Owner and Principal Consultant at Phase 1 Consulting, LLC.

Amy DiRico attended Middlebury College from 1990 to 1994, where they earned a Bachelor of Arts in Chemistry.